Viridian Therapeutics, Inc.\DE (VRDN) Net Margin Growth (5y) (2018 - 2026)
Viridian Therapeutics, Inc.\DE (VRDN) Net Margin Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Viridian Therapeutics, Inc.\DE | 631.55 Mn | 631.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.80 Mn |
| Dec 31, 2025 | 9.30 Mn |
| Jun 30, 2025 | -14.51 Mn |
| Mar 31, 2025 | -12.98 Mn |
| Dec 31, 2024 | -10.87 Mn |
| Sep 30, 2024 | -10.55 Mn |
| Jun 30, 2024 | -10.11 Mn |
| Mar 31, 2024 | -7.70 Mn |
| Dec 31, 2023 | -11.47 Mn |
| Sep 30, 2023 | -6.52 Mn |
| Jun 30, 2023 | -7.61 Mn |
| Mar 31, 2023 | -6.95 Mn |
| Dec 31, 2022 | -4.29 Mn |
| Sep 30, 2022 | -206,415.00 |
| Jun 30, 2022 | -1.05 Mn |
| Mar 31, 2022 | -1.04 Mn |
| Dec 31, 2021 | -1.24 Mn |
| Sep 30, 2021 | -630,636.00 |
| Jun 30, 2021 | -133,094.00 |
| Mar 31, 2021 | -87,582.00 |